- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09.10. | Asahi Kasei Launches Sonanos Next-Gen Excipients | ||
| 09.10. | Bio-Thera Solutions & Intas Pharmaceuticals Expand Partnership | ||
| 09.10. | Expedition Therapeutics Raises $165 Million in Oversubscribed Series A | ||
| 09.10. | Navidea Biopharmaceuticals Files for Chapter 11 Bankruptcy | ||
| 09.10. | Mission Bio Taps Dr. Zivjena Vucetic as Chief Medical Officer | ||
| 08.10. | groninger Group Builds State-of-the-Art Assembly Hall at Crailsheim HQ | ||
| 08.10. | KLIFO Gets Approval for New Clinical Trial Supply Facility in Copenhagen | ||
| 08.10. | Enzene is the First Indian Company to Partner with Virtuosi | ||
| 08.10. | Lonza Completes New Drug Product Filling Line in Stein, Switzerland | ||
| 08.10. | BD & Opentrons Accelerate Single-Cell Multiomics Discoveries | ||
| 08.10. | FairJourney Biologics Appoints Dr. Werner Lanthaler as CEO | ||
| 08.10. | Boehringer Ingelheim Acquires Preclinical Oncology Asset from Accent Therapeutics | ||
| 08.10. | Aptamer Enters Development Agreement with Top 3 Global Pharma Company | ||
| 07.10. | Molcure, Boehringer Ingelheim Sign Multi-Year AI-Driven Antibody Discovery Agreement | ||
| 07.10. | Lilly to Invest $1B in India to Expand Manufacturing Capacity | ||
| 07.10. | Steriline to Present Robotic Filling Line at CPHI Frankfurt 2025 | ||
| 07.10. | Piramal Pharma Solutions Implements POD Method at Aurora API Facility | ||
| 07.10. | Kincell Bio Advances Moonlight Bio's T Cell Candidate | ||
| 07.10. | Merck Completes Acquisition of Verona Pharma | ||
| 07.10. | Celonic, Carbogen Amcis Partner to Offer Integrated ADC Development & Manufacturing | ||
| 06.10. | Algen and AstraZeneca Forge AI-Driven Drug Discovery Partnership | ||
| 06.10. | ROVI Rebrands as ROIS, Acquires U.S. Injectable Manufacturing Site | ||
| 06.10. | Asimov Unveils Stable AAV Manufacturing Platform | ||
| 06.10. | Rentschler Biopharma Expands Services in Japan & South Korea | ||
| 06.10. | Lonza Expands Cell and Gene Therapy Portfolio |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .